Featured Articles
Patients from the Corrona registry, an independent, observational US registry housing data on patients with rheumatic diseases, were included in Dr Harrold and colleagues’ study if they had received a PsA diagnosis; had initiated therapy with a TNFi (ie, adalimumab, etanercept, golimumab, or infliximab) between October 1, 2002, and March 21, 2013; and were aged ≥18 years.
Advances in contemporary imaging techniques have led to more widespread use of this modality for the management of osteoarthritis (OA). However, in the absence of evidence-based guidelines, imaging is often used in circumstances where it does not change management.
Dr Verstappen and colleagues had previously shown that patients treated within 6 months of symptom onset had improved 10-year outcomes compared with those who were treated later.
Based on the results of their study, Dr Grainger and colleagues asserted that current mobile applications available to assist in the management of patients with RA are configured as simple calculators for rheumatologists or as data tracking tools for patients, and the latter do not uniformly collect data using validated instruments.
Personalized Medicine
The multibiomarker disease activity (MBDA) scale appears to be a very versatile tool, based on results presented at the 2015 annual meeting of the American College of Rheumatology.
The Rheumatology Nurse
The certification through portfolio
process can be used to promote
the rheumatology nurse’s professional
development and performance,
said Sheree C. Carter, PhD, RN,
at the 2015 Annual Conference of the
Rheumatology Nurses Society (RNS).
